5-amino-1mq supplier price 5 amino-1mq peptide Peptide 5-Amino-1MQ

A 12-week randomized trial demonstrated: Average weight loss of 2.6 kg in AOD-9604 group (1 mg/day) versus 0.8 kg in placebo group Preferential reduction in abdominal and visceral fat deposits No adverse effects on carbohydrate metabolism or insulin sensitivity Non-dose-dependent effects, with higher doses (10 mg/day) producing less weight loss than lower doses However, a subsequent 24-week Phase III trial with 502 subjects incorporating intensive diet and exercise showed no statistically significant weight loss compared to placebo, leading to development termination in 2007

He Y, Sun MM, Zhang GG, Yang J, Chen KS, Xu WW, Li B

It is commonly used in in-vitro experiments investigating metabolic regulation and enzymatic signaling pathways

Block NNMT with 5-Amino-1MQ and SAM piles up